Publication
Article
Dermatology Times
Author(s):
CBD skin care is booming, but are patients getting real benefits? Learn about CBD legality, safety, and potential dermatologic effects.
CBD, an abbreviation for cannabidiol, is showing up everywhere in skin care products. In 2025, the CBD skin care market is expected to hit $1.7 billion, which is more than the annual sales of most prescription dermatology drugs. Are patients spending their money wisely on CBD products or wasting valuable resources?
Cannabidiol is a compound naturally found in the Cannabis sativa plant, whose family includes hemp plants and marijuana. Hemp plants contain abundant CBD and almost no THC, or delta-9-tetrahydrocannabinol, which is the psychoactive drug in marijuana. For this reason, most CBD is derived from industrial hemp plants.
Yes, CBD products are legal. In 2018, the Farm Bill that was passed removed hemp from the legal definition of marijuana.1 This made hemp-based CBD products with less than 0.3% THC federally legal. CBD products with more than 0.3% THC may be federally illegal, but they are legal under some state laws; however, the federal government does not habitually enforce the law against these products.
No, hemp seed oil is not the same as CBD. CBD oil is extracted from the leaves and flowers of the hemp plant, but hemp oil is extracted from the seeds of the Cannabis sativa plant. CBD oil is lighter than hemp seed oil, which is much greasier.
Finding safe CBD products can be challenging as most are manufactured by small companies. The following recommendations might help patients avoid CBD issues:
Several essential industry terms are used to describe CBD products to the consumer. Those that dermatologists should understand are listed below:
It is amazing to think that the human body contains a highly conserved network of endocannabinoid molecular signaling that is important in bodily homeostasis. Endocannabinoid dysregulation is thought to lead to atopic dermatitis, itch, pigmentation, hair growth, and acne. Cannabinoid 2 receptors are found in keratinocytes, nerves, melanocytes, eccrine glands, and hair follicles. The main benefits of CBD are purported to include the following:
However, CBD is difficult to deliver into the skin due to its molecular weight (314.46 Da), and much of topically applied CBD may reside on the skin surface unless a carrier system is utilized.
Zoe Diana Draelos, MD, is a consulting professor of dermatology at Duke University School of Medicine in Durham, North Carolina, and Dermatology Times’ editor in chief emeritus.
Reference